WiQo (via WiQo US) Acquires Love Beauty Pro & Medical to Expand U.S. Presence

ARCHIMED Acquires WiQo S.p.A.

March 9, 2023

Medical Devices

ARCHIMED, a Europe-based healthcare private equity firm, has acquired WiQo, an Italian developer and manufacturer of the PRX‑T33 topical biostimulator used in aesthetic medicine. Founders (Dr. Rossana Castellana and family) retained a 25% stake and Castellana will stay on to lead R&D; the deal was financed with debt provided by Banco BPM and Crédit Agricole Italia and is the fourth investment from ARCHIMED's MED III fund.

ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera

November 17, 2023

Healthcare Services

ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.

Yellow Wood Partners Acquires Elida Beauty from Unilever

June 6, 2024

Consumer Products

Yellow Wood Partners completed the acquisition of Elida Beauty, a portfolio of legacy Unilever beauty and personal care brands (including Q-tips, Caress, Ponds for North America/Europe, Impulse, Noxzema, Monsavon and Timotei). The transaction is a corporate carve-out from Unilever; Yellow Wood will operate Elida Beauty as an independent company with offices in Dallas, London and Paris and has named Alfie Vivian as CEO to lead the next phase of growth.

iuvo BioScience Acquires Promedica International

January 18, 2024

Healthcare Services

iuvo BioScience, a Rochester-based specialty preclinical and clinical services provider backed by Ampersand Capital Partners, has acquired Promedica International, an ophthalmology-focused clinical CRO headquartered in Costa Mesa, California. The deal combines iuvo's laboratory and consulting capabilities with Promedica's ophthalmic clinical trial expertise to create an integrated end-to-end ophthalmology clinical research offering.

SBC Medical Group Holdings Acquires Controlling Stake in Waqoo, Inc.

December 19, 2025

Biotechnology

SBC Medical Group Holdings announced the final results of a tender offer to acquire up to 575,052 common shares of Waqoo, Inc. at JPY 1,900 per share, representing a total investment of approximately JPY 1,092.5 million. With an off-market transfer of remaining shares from major shareholder Yoshiyuki Aikawa, SBC Medical's ownership of Waqoo is expected to exceed 50%, making SBC the parent company to strengthen its regenerative-medicine R&D capabilities and presence in Japan.

Rhyz Inc. (Nu Skin) Acquires BeautyBio

August 1, 2023

Consumer Products

Rhyz Inc., the strategic investment arm of Nu Skin Enterprises, announced the acquisition of BeautyBio, an omnichannel skincare and beauty device brand. Nu Skin said the deal will add BeautyBio's device IP and product portfolio to its ecosystem to drive growth, cost efficiencies and strengthen its position in at-home beauty devices.